Alongside observational and academic studies, we run a range of clinical trials. Please see below the full list of currently open trials and contact details if you are interested in finding out more.

CTH-302

Phase III trial looking at the use of sublingual apomorphine in patients with advanced Parkinson’s Disease. Sponsor: Sunovion.
Currently recruiting. Contact: aleksandra.podlewska@nhs.net

FAIRPARK-II

Phase II trial looking to examine the efficacy and tolerance of an iron-binding treatment, deferiprone, which reduces the accumulation of iron in the brain, in order to limit the development of Parkinson’s disease. Sponsor: EU. Currently recruiting de novo patients. Contact: dhaval.trivedi1@nhs.net